{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:11:00Z","timestamp":1784956260031,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","award":["HD096723"],"award-info":[{"award-number":["HD096723"]}],"id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00471-x","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T15:01:07Z","timestamp":1748271667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection rates of multigene panel and exome testing in patients with previous negative BRCA1\/2 results"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5044-7103","authenticated-orcid":false,"given":"Jewel L.","family":"Wasson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-8328","authenticated-orcid":false,"given":"Trinity N.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7999-2804","authenticated-orcid":false,"given":"Darcy L.","family":"Thull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4049-1506","authenticated-orcid":false,"given":"Maureen","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-3471","authenticated-orcid":false,"given":"Shenin A.","family":"Sanoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Yatsenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bellissimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-4974","authenticated-orcid":false,"given":"Phuong L.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"471_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B et al (2016) Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet 53:465\u2013471. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103672","journal-title":"J Med Genet"},{"key":"471_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","volume":"2","author":"BM Norquist","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF et al (2016) Inherited mutations in women with ovarian carcinoma. JAMA Oncol 2:482\u2013490. https:\/\/doi.org\/10.1001\/jamaoncol.2015.5495","journal-title":"JAMA Oncol"},{"key":"471_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1200\/JCO.2002.20.4.994","volume":"20","author":"HA Shih","year":"2002","unstructured":"Shih HA, Couch FJ, Nathanson KL et al (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 20:994\u2013999. https:\/\/doi.org\/10.1200\/JCO.2002.20.4.994","journal-title":"J Clin Oncol"},{"key":"471_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.30428","volume":"140","author":"C Kraus","year":"2017","unstructured":"Kraus C, Hoyer J, Vasileiou G et al (2017) Gene panel sequencing in familial breast\/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1\/2. Int J Cancer 140:95\u2013102. https:\/\/doi.org\/10.1002\/ijc.30428","journal-title":"Int J Cancer"},{"key":"471_CR5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J et al (2016) Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34:1460\u20131468. https:\/\/doi.org\/10.1200\/JCO.2015.65.0747","journal-title":"J Clin Oncol"},{"key":"471_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-018-4726-x","volume":"170","author":"J Singh","year":"2018","unstructured":"Singh J, Thota N, Singh S et al (2018) Screening of over 1000 Indian patients with breast and\/or ovarian cancer with a multi-gene panel: prevalence of BRCA1\/2 and non-BRCA mutations. Breast Cancer Res Treat 170:189\u2013196. https:\/\/doi.org\/10.1007\/s10549-018-4726-x","journal-title":"Breast Cancer Res Treat"},{"key":"471_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00432-020-03377-6","volume":"147","author":"J Lerner-Ellis","year":"2021","unstructured":"Lerner-Ellis J, Mighton C, Lazaro C et al (2021) Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario. J Cancer Res Clin Oncol 147:871\u2013879. https:\/\/doi.org\/10.1007\/s00432-020-03377-6","journal-title":"J Cancer Res Clin Oncol"},{"key":"471_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A et al (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123:1721\u20131730. https:\/\/doi.org\/10.1002\/cncr.30498","journal-title":"Cancer"},{"key":"471_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C et al (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol 3:1190\u20131196. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","journal-title":"JAMA Oncol"},{"key":"471_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R et al (2016) Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med 18:823\u2013832. https:\/\/doi.org\/10.1038\/gim.2015.166","journal-title":"Genet Med"},{"key":"471_CR11","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s10897-017-0099-2","volume":"26","author":"GW Hooker","year":"2017","unstructured":"Hooker GW, Clemens KR, Quillin J et al (2017) Cancer genetic counseling and testing in an era of rapid change. J Genet Couns 26:1244\u20131253. https:\/\/doi.org\/10.1007\/s10897-017-0099-2","journal-title":"J Genet Couns"},{"key":"471_CR12","unstructured":"National Comprehensive Cancer Network (2024) Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic (version 3.2024)"},{"key":"471_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-genom-091416-035305","volume":"18","author":"PD Shah","year":"2017","unstructured":"Shah PD, Nathanson KL (2017) Application of panel-based tests for inherited risk of cancer. Annu Rev Genomics Hum Genet 18:201\u2013227. https:\/\/doi.org\/10.1146\/annurev-genom-091416-035305","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"471_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41436-019-0633-8","volume":"22","author":"H LaDuca","year":"2020","unstructured":"LaDuca H, Polley EC, Yussuf A et al (2020) A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet Med 22:407\u2013415. https:\/\/doi.org\/10.1038\/s41436-019-0633-8","journal-title":"Genet Med"},{"key":"471_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/jgc4.1513","volume":"31","author":"R Mooney","year":"2022","unstructured":"Mooney R, Espinel W, Elrick A et al (2022) Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing. J Genet Couns 31:470\u2013478. https:\/\/doi.org\/10.1002\/jgc4.1513","journal-title":"J Genet Couns"},{"key":"471_CR16","doi-asserted-by":"publisher","first-page":"50930","DOI":"10.18632\/oncotarget.15871","volume":"8","author":"E Dicks","year":"2017","unstructured":"AOCS Study Group, Dicks E, Song H et al (2017) Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget 8:50930\u201350940. https:\/\/doi.org\/10.18632\/oncotarget.15871","journal-title":"Oncotarget"},{"key":"471_CR17","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","volume":"111","author":"JI Kiiski","year":"2014","unstructured":"Kiiski JI, Pelttari LM, Khan S et al (2014) Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc Natl Acad Sci 111:15172\u201315177. https:\/\/doi.org\/10.1073\/pnas.1407909111","journal-title":"Proc Natl Acad Sci"},{"key":"471_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ng.3284","volume":"47","author":"C Cybulski","year":"2015","unstructured":"Cybulski C, Carrot-Zhang J, Klu\u017aniak W et al (2015) Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet 47:643\u2013646. https:\/\/doi.org\/10.1038\/ng.3284","journal-title":"Nat Genet"},{"key":"471_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/humu.23732","volume":"40","author":"A Tavera-Tapia","year":"2019","unstructured":"Tavera-Tapia A, de la Hoya M, Calvete O et al (2019) RECQL5: another DNA helicase potentially involved in hereditary breast cancer susceptibility. Hum Mutat 40:566\u2013577. https:\/\/doi.org\/10.1002\/humu.23732","journal-title":"Hum Mutat"},{"key":"471_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002894","volume":"8","author":"ER Thompson","year":"2012","unstructured":"Thompson ER, Doyle MA, Ryland GL et al (2012) Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet 8:e1002894. https:\/\/doi.org\/10.1371\/journal.pgen.1002894","journal-title":"PLoS Genet"},{"key":"471_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/humu.24158","volume":"42","author":"PS Felicio","year":"2021","unstructured":"Felicio PS, Grasel RS, Campacci N et al (2021) Whole-exome sequencing of non-BRCA1\/BRCA2 mutation carrier cases at high-risk for hereditary breast\/ovarian cancer. Hum Mutat 42:290\u2013299. https:\/\/doi.org\/10.1002\/humu.24158","journal-title":"Hum Mutat"},{"key":"471_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fgene.2019.01005","volume":"10","author":"S Glentis","year":"2019","unstructured":"Glentis S, Dimopoulos AC, Rouskas K et al (2019) Exome sequencing in BRCA1- and BRCA2-negative Greek families identifies MDM1 and NBEAL1 as candidate risk genes for hereditary breast cancer. Front Genet 10:1005. https:\/\/doi.org\/10.3389\/fgene.2019.01005","journal-title":"Front Genet"},{"key":"471_CR23","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/ijc.32545","volume":"146","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Zhang J, Chen Y et al (2020) Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes. Int J Cancer 146:2147\u20132155. https:\/\/doi.org\/10.1002\/ijc.32545","journal-title":"Int J Cancer"},{"key":"471_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12885-019-5494-7","volume":"19","author":"RB Shahi","year":"2019","unstructured":"Shahi RB, De Brakeleer S, Caljon B et al (2019) Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. BMC Cancer 19:313. https:\/\/doi.org\/10.1186\/s12885-019-5494-7","journal-title":"BMC Cancer"},{"key":"471_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40246-022-00435-7","volume":"16","author":"NY Lee","year":"2022","unstructured":"Lee NY, Hum M, Amali AA et al (2022) Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility. Hum Genomics 16:61. https:\/\/doi.org\/10.1186\/s40246-022-00435-7","journal-title":"Hum Genomics"},{"key":"471_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"471_CR27","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1158\/1078-0432.CCR-09-3058","volume":"16","author":"MD Walsh","year":"2010","unstructured":"Walsh MD, Buchanan DD, Cummings MC et al (2010) Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res 16:2214\u20132224. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-3058","journal-title":"Clin Cancer Res"},{"key":"471_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1078-0432.CCR-21-2027","volume":"28","author":"CJ Schwartz","year":"2022","unstructured":"Schwartz CJ, Da Silva EM, Marra A et al (2022) Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome. Clin Cancer Res 28:404\u2013413. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2027","journal-title":"Clin Cancer Res"},{"key":"471_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","volume":"22","author":"M Dominguez-Valentin","year":"2020","unstructured":"Dominguez-Valentin M, Sampson JR, Sepp\u00e4l\u00e4 TT et al (2020) Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med 22:15\u201325. https:\/\/doi.org\/10.1038\/s41436-019-0596-9","journal-title":"Genet Med"},{"key":"471_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10897-014-9796-2","volume":"24","author":"J Doherty","year":"2015","unstructured":"Doherty J, Bonadies DC, Matloff ET (2015) Testing for hereditary breast cancer: panel or targeted testing? Experience from a clinical cancer genetics practice. J Genet Couns 24:683\u2013687. https:\/\/doi.org\/10.1007\/s10897-014-9796-2","journal-title":"J Genet Couns"},{"key":"471_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13053-017-0083-8","volume":"16","author":"SA Gardner","year":"2018","unstructured":"Gardner SA, Weymouth KS, Kelly WS et al (2018) Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory. Hered Cancer Clin Pract 16:1. https:\/\/doi.org\/10.1186\/s13053-017-0083-8","journal-title":"Hered Cancer Clin Pract"},{"key":"471_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.39571","volume":"6","author":"E Chen","year":"2023","unstructured":"Chen E, Facio FM, Aradhya KW et al (2023) Rates and classification of variants of uncertain significance in hereditary disease genetic testing. JAMA Netw Open 6:e2339571. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.39571","journal-title":"JAMA Netw Open"},{"key":"471_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12920-023-01437-7","volume":"16","author":"F Adam","year":"2023","unstructured":"Adam F, Fluri M, Scherz A, Rabaglio M (2023) Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study. BMC Med Genomics 16:7. https:\/\/doi.org\/10.1186\/s12920-023-01437-7","journal-title":"BMC Med Genomics"},{"key":"471_CR34","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00020","author":"L Esterling","year":"2020","unstructured":"Esterling L, Wijayatunge R, Brown K et al (2020) Impact of a cancer gene variant reclassification program over a 20-year period. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.20.00020","journal-title":"JCO Precis Oncol"},{"key":"471_CR35","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2018.13152","volume":"320","author":"J Mersch","year":"2018","unstructured":"Mersch J, Brown N, Pirzadeh-Miller S et al (2018) Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA 320:1266. https:\/\/doi.org\/10.1001\/jama.2018.13152","journal-title":"JAMA"},{"key":"471_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/gim.2017.207","volume":"20","author":"S Macklin","year":"2018","unstructured":"Macklin S, Durand N, Atwal P, Hines S (2018) Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. Genet Med 20:346\u2013350. https:\/\/doi.org\/10.1038\/gim.2017.207","journal-title":"Genet Med"},{"key":"471_CR37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00662","author":"N Tung","year":"2024","unstructured":"Tung N, Ricker C, Messersmith H et al (2024) Selection of germline genetic testing panels in patients with cancer: ASCO guideline. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.24.00662","journal-title":"J Clin Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00471-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:57:47Z","timestamp":1750913867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00471-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00471-x","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"48"}}